Bone tropic peptides

Details Bone tropic peptides Bone tropic peptides

2011-01-18

2011-01-18

Tsang, Cecilia (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

07871978

ABSTRACT:
The present invention is directed to the use of bone tropic peptides identified through the use of a phage display library. More particularly, the invention is directed to compositions comprising the bone tropic peptides and methods for using such compositions to regulate osteogenesis, cell adhesion and angiogenesis, and diseases and disorders thereof, and to inhibit cancer cell metastasis and growth.

REFERENCES:
patent: 5683459 (1997-11-01), Brekke
patent: 6541024 (2003-04-01), Kadiyala et al.
patent: 7323542 (2008-01-01), Balian
patent: 2003/0092077 (2003-05-01), Ramarao
patent: 2003/0113714 (2003-06-01), Belcher et al.
patent: 2003/0166004 (2003-09-01), Gyuris et al.
patent: 2004/0171552 (2004-09-01), Peled et al.
patent: 2005/0085623 (2005-04-01), Balian et al.
patent: WO 02/02593 (2002-01-01), None
patent: WO 03/072593 (2003-09-01), None
Christian et al. Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. JCB, Nov. 24, 2003, pp. 871-878.
Sporn et al. Chemoprevention of cancer. Carcinogenesis. 2000. vol. 21, No. 3, pp. 525-530.
Bab et al. Histone H4-related osteogenic growth peptide (OGP): a novel circulating stimulator of osteoblastic activity. The EMBO Journal. 1992. vol. 11, Nol. 5, pp. 1867-1873.

Affiliated with

Also associated with

Rating

Bone tropic peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bone tropic peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bone tropic peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2654677